Literature DB >> 21422822

Nidovirus ribonucleases: Structures and functions in viral replication.

Rachel Ulferts1, John Ziebuhr.   

Abstract

Nidoviruses employ unique strategies to replicate and express their exceptionally large RNA genomes. The viruses use a variety of enzymes to synthesize, modify and process an extensive set of viral RNAs of both genome and subgenome length, including RNA polymerase, primase, helicase, ribose 2'-O and guanosine-N7 methyltransferases and several types of nuclease activities. In this review, the recent progress in the structural and functional characterization of nidovirus nuclease activities is discussed, focusing on a nidovirus-wide conserved uridylate-specific endoribonuclease, NendoU, and a 3'-to-5' exoribonuclease called ExoN. The latter enzyme is related to members of the DEDD exoribonuclease superfamily and conserved in all nidovirus families with genome sizes approaching 30 kilobases. Recent evidence implicates ExoN in reduced mutation rates during viral RNA replication and, possibly, superior fidelity of nidovirus replicases, leading to the suggestion that ExoN may be a key factor in the expansion of nidovirus genomes to sizes not seen in other RNA viruses.

Mesh:

Substances:

Year:  2011        PMID: 21422822     DOI: 10.4161/rna.8.2.15196

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  34 in total

1.  RNA virus replication, transcription and recombination.

Authors:  K Andrew White; Luis Enjuanes; Ben Berkhout
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

Review 2.  Trans-acting regulators of ribonuclease activity.

Authors:  Jaejin Lee; Minho Lee; Kangseok Lee
Journal:  J Microbiol       Date:  2021-02-10       Impact factor: 3.422

3.  Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis.

Authors:  Ibrahim M Ibrahim; Abdo A Elfiky; Mohamed M Fathy; Sara H Mahmoud; Mahmoud ElHefnawi
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

4.  A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations.

Authors:  Sumit Kumar; Yash Gupta; Samantha E Zak; Charu Upadhyay; Neha Sharma; Andrew S Herbert; Ravi Durvasula; Vladimir Potemkin; John M Dye; Prakasha Kempaiah; Brijesh Rathi
Journal:  RSC Med Chem       Date:  2021-08-18

Review 5.  The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.

Authors:  E J Snijder; E Decroly; J Ziebuhr
Journal:  Adv Virus Res       Date:  2016-09-14       Impact factor: 9.937

6.  Correlation between mutation rate and genome size in riboviruses: mutation rate of bacteriophage Qβ.

Authors:  Katie Bradwell; Marine Combe; Pilar Domingo-Calap; Rafael Sanjuán
Journal:  Genetics       Date:  2013-07-12       Impact factor: 4.562

Review 7.  An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Mohammad Abul Farah; Khalid Mashay Al-Anazi
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

8.  Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.

Authors:  Berta Canal; Ryo Fujisawa; Allison W McClure; Tom D Deegan; Mary Wu; Rachel Ulferts; Florian Weissmann; Lucy S Drury; Agustina P Bertolin; Jingkun Zeng; Rupert Beale; Michael Howell; Karim Labib; John F X Diffley
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

9.  Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes.

Authors:  Kira S Makarova; Vivek Anantharaman; L Aravind; Eugene V Koonin
Journal:  Biol Direct       Date:  2012-11-14       Impact factor: 4.540

10.  Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing.

Authors:  Vivek Anantharaman; Kira S Makarova; A Maxwell Burroughs; Eugene V Koonin; L Aravind
Journal:  Biol Direct       Date:  2013-06-15       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.